Headed to ASCO 2026? Meet the HiRO Team in Chicago BlogsHiRO Updates

Headed to ASCO 2026? Meet the HiRO Team in Chicago

HiRO will be Attending the ASCO Annual Meeting: Advancing Oncology Innovation | Visit Us at…

harvestiroMay 1, 2026

Clinical Research Consulting vs. FSP in Biotech and Pharma: Knowing When an FSP Is the Right Fit  Blogs

Clinical Research Consulting vs. FSP in Biotech and Pharma: Knowing When an FSP Is the Right Fit 

Clinical Research Consulting vs. FSP: Choosing the Right Model for Biotech and Pharma Companies Biotech…

harvestiroApril 28, 2026

CRM Trial Connect 2026 Kuala Lumpur: Where to Find HiRO and What’s New BlogsHiRO Updates

CRM Trial Connect 2026 Kuala Lumpur: Where to Find HiRO and What’s New

HiRO Attending CRM Trial Connect 2026 in Kuala Lumpur HiRO will be attending CRM Trial…

harvestiroApril 23, 2026

Advancing Cross‑Border Clinical Development: HiRO at BIO Korea 2026 BlogsHiRO Updates

Advancing Cross‑Border Clinical Development: HiRO at BIO Korea 2026

HiRO to Attend BIO Korea 2026, April 28–30 in Seoul HiRO is excited to announce…

harvestiroApril 20, 2026

Meet HiRO at COG New England Conference on April 28-29! BlogsHiRO Updates

Meet HiRO at COG New England Conference on April 28-29!

HiRO to Attend COG New England Conference, April 28–29 Clinical development is becoming increasingly global,…

harvestiroApril 20, 2026

China’s Order No. 818: What Foreign Biotech Companies Need to Know About IITs for Cell and Gene Therapy BlogsHiRO Updates

China’s Order No. 818: What Foreign Biotech Companies Need to Know About IITs for Cell and Gene Therapy

China’s Order No. 818: What Foreign Biotech Companies Need to Know About IITs for Cell…

harvestiroApril 17, 2026

Connect with HiRO at the 2026 AAD Annual Meeting in Denver – Booth #209 HiRO Updates

Connect with HiRO at the 2026 AAD Annual Meeting in Denver – Booth #209

Heading to the 2026 AAD Annual Meeting? Connect with the HiRO Team in Denver The…

harvestiroMarch 30, 2026

Meet HiRO at PHUSE US Connect 2026 in Austin – Booth #26 HiRO Updates

Meet HiRO at PHUSE US Connect 2026 in Austin – Booth #26

We’re excited to join PHUSE US Connect 2026, taking place March 22–26, 2026 in Austin,…

harvestiroMarch 30, 2026

HiRO Leads Cross‑Border Dialogue at JPM, Offering Insights for Biotechs Seeking Asian Investment HiRO Updates

HiRO Leads Cross‑Border Dialogue at JPM, Offering Insights for Biotechs Seeking Asian Investment

SOMERSET, N.J., March 3, 2026 -- Harvest Integrated Research Organization (HiRO), a global contract research…

Vicky HuiMarch 3, 2026

Successful Rescue and Transition of a Phase I Oncology Study for a US Biotech Company Case Studies

Successful Rescue and Transition of a Phase I Oncology Study for a US Biotech Company

Overview A US biotech company's Phase I oncology study had stalled under the management of…

Vicky HuiJanuary 29, 2026

Rescuing a Rare Disease Trial: Accelerating MRCT RA Submissions for a Taiwan Biotech Company Case Studies

Rescuing a Rare Disease Trial: Accelerating MRCT RA Submissions for a Taiwan Biotech Company

This case study highlights HiRO's effective intervention in accelerating the regulatory submission process for a…

Vicky HuiJanuary 29, 2026

Understanding the US FDA’s Special Designations and Approval Pathways Blogs

Understanding the US FDA’s Special Designations and Approval Pathways

Recognizing the challenges of drug development, the US FDA has established several special designations and…

Vicky HuiJanuary 26, 2026